Trevi Therapeutics Inc. (TRVI)
Market Open
3 Mar, 15:49
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 18
-0.39
-3.14%
$
1.53B Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.39 Eps
$ 12.57
Previous Close Day Range
11.92 12.51
Year Range
4.22 14.39
Want to track TRVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TRVI earnings report is expected in 14 days (17 Mar 2026)
Trevi Therapeutics, Inc. (TRVI) Q2 2024 Earnings Call Transcript
Trevi Therapeutics, Inc. (NASDAQ:TRVI ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Jennifer Good - President and CEO Lisa Delfini - Chief Financial Officer David Clark - Chief Medical Officer Conference Call Participants Thomas Smith - Leerink Partners Leland Gershell - Oppenheimer Mayank Mamtani - B. Riley Securities Brandon Folkes - Rodman & Renshaw John Gionco - Needham & Company Debanjana Chatterjee - JonesTrading Operator Good afternoon.
Seekingalpha | 1 year ago
